fluoxetine and iloprost

fluoxetine has been researched along with iloprost in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
De Broucker, T; Lhote, F1
Archer, SL; Michelakis, ED1

Reviews

1 review(s) available for fluoxetine and iloprost

ArticleYear
An evidence-based approach to the management of pulmonary arterial hypertension.
    Current opinion in cardiology, 2006, Volume: 21, Issue:4

    Topics: Antihypertensive Agents; Benzamides; Bosentan; Calcium Channel Blockers; Comorbidity; Dichloroacetic Acid; Drug Therapy, Combination; Epoprostenol; Evidence-Based Medicine; Fluoxetine; Humans; Hypertension, Pulmonary; Iloprost; Imatinib Mesylate; Isoxazoles; Phosphodiesterase Inhibitors; Piperazines; Prostaglandins, Synthetic; Pulmonary Artery; Purines; Pyrimidines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Simvastatin; Sulfonamides; Sulfones; Thiophenes; Vasodilator Agents

2006

Other Studies

2 other study(ies) available for fluoxetine and iloprost

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
[Severe Raynaud's phenomenon associated with interferon-beta 1a and fluoxetine].
    Annales de medecine interne, 2000, Volume: 151, Issue:5

    Topics: Adjuvants, Immunologic; Adult; Anticoagulants; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Heparin; Humans; Iloprost; Interferon beta-1a; Interferon-beta; Multiple Sclerosis, Relapsing-Remitting; Raynaud Disease; Vasodilator Agents

2000